Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
Glutamate, a crucial excitatory neurotransmitter, plays a major role in the modulation of schizophrenia’s pathogenesis. New drug developments for schizophrenia have been prompted by the hypoglutamatergic hypothesis of schizophrenia. The cystine/glutamate antiporter system x<sub>c</sub>&l...
Main Authors: | Chung-Chieh Hung, Chieh-Hsin Lin, Hsien-Yuan Lane |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/18/9718 |
Similar Items
-
Change of Cystine/Glutamate Antiporter Expression in Ethanol-Dependent Rats
by: Alessandra Tiziana Peana, et al.
Published: (2014-10-01) -
Structural investigation of human cystine/glutamate antiporter system xc− (Sxc−) using homology modeling and molecular dynamics
by: Tran Dieu Hang, et al.
Published: (2022-12-01) -
Glutamate signalling in bone.
by: Karen eBrakspear, et al.
Published: (2012-08-01) -
The initiator of neuroexcitotoxicity and ferroptosis in ischemic stroke: Glutamate accumulation
by: Genhao Fan, et al.
Published: (2023-03-01) -
Cystine-dependent antiporters buffer against excess intracellular reactive sulfur species-induced stress
by: Masahiro Akiyama, et al.
Published: (2022-11-01)